390 related articles for article (PubMed ID: 27742220)
21. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
[TBL] [Abstract][Full Text] [Related]
23. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
24. Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
Singh AK; Wang X; Sun W
Vaccine; 2020 May; 38(21):3720-3728. PubMed ID: 32278523
[TBL] [Abstract][Full Text] [Related]
25. Protection Induced by Oral Vaccination with a Recombinant
Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
[TBL] [Abstract][Full Text] [Related]
26. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
[TBL] [Abstract][Full Text] [Related]
27. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J
Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295
[TBL] [Abstract][Full Text] [Related]
28. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
29. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
Sagi S; Konduru B; Parida M
Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
[TBL] [Abstract][Full Text] [Related]
30. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
Galen JE; Wang JY; Carrasco JA; Lloyd SA; Mellado-Sanchez G; Diaz-McNair J; Franco O; Buskirk AD; Nataro JP; Pasetti MF
Infect Immun; 2015 Jan; 83(1):161-72. PubMed ID: 25332120
[TBL] [Abstract][Full Text] [Related]
31. Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes.
Kubicek-Sutherland JZ; Heithoff DM; Ersoy SC; Shimp WR; Mahan MJ
Vaccine; 2014 Mar; 32(13):1451-9. PubMed ID: 24508035
[TBL] [Abstract][Full Text] [Related]
32. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
Li P; Wang X; Sun X; Guan Z; Sun W
mSphere; 2021 Oct; 6(5):e0069921. PubMed ID: 34612675
[TBL] [Abstract][Full Text] [Related]
33. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
[TBL] [Abstract][Full Text] [Related]
34. Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection.
Ramirez K; Ditamo Y; Rodriguez L; Picking WL; van Roosmalen ML; Leenhouts K; Pasetti MF
Mucosal Immunol; 2010 Mar; 3(2):159-71. PubMed ID: 19924118
[TBL] [Abstract][Full Text] [Related]
35. Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia.
Balada-Llasat JM; Panilaitis B; Kaplan D; Mecsas J
Vaccine; 2007 Feb; 25(8):1526-33. PubMed ID: 17194509
[TBL] [Abstract][Full Text] [Related]
36. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
Wozniak A; Scioscia N; García PC; Dale JB; Paillavil BA; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM
Microbiol Immunol; 2018 Jun; 62(6):395-404. PubMed ID: 29704396
[TBL] [Abstract][Full Text] [Related]
37. A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase.
Tsugo K; Nakamura SI; Yamanaka H; Une Y
J Vet Med Sci; 2017 May; 79(5):855-863. PubMed ID: 28320976
[TBL] [Abstract][Full Text] [Related]
38. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors.
Bahey-El-Din M; Casey PG; Griffin BT; Gahan CGM
J Med Microbiol; 2010 Aug; 59(Pt 8):904-912. PubMed ID: 20488938
[TBL] [Abstract][Full Text] [Related]
39. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
40. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
Philipovskiy AV; Smiley ST
Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
